AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

6,794.00p
   
  • Change Today:
    -348.00p
  • 52 Week High: 7,878.00p
  • 52 Week Low: 5,644.00p
  • Currency: UK Pounds
  • Shares Issued: 1,312.19m
  • Volume: 4,469,668
  • Market Cap: 89,150m
  • RiskGrade: 142

AstraZeneca Overview

A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

AstraZeneca Financials

Latest F'cast
Div Yield 3.2% 2.8%
Div Cover 0.4 1.5
Op Mrgn 12.0% 25.0%
ROCE 76.9%  
Latest F'cast
P/E 84.2 21.2
PEG n/a 0.1
Pr/Revenue 4.7 4.3
Pr/Book 7.8  
Latest F'cast
Revenue 10.4% -33.9%
PBT -22.3% 160.4%
EPS -39.4% 302.6%
DPS n/a -39.7%

AstraZeneca Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-15 24,708.00 3,069.00 426.00¢ 13.9 n/a -0% 280.00¢ 4.7%
31-Dec-16 23,002.00 3,552.00 431.00¢ 13.2 13.2 +1% 280.00¢ 4.9%
31-Dec-17 22,465.00 2,227.00 428.00¢ 15.3 n/a -1% 280.00¢ 4.3%
31-Dec-18 22,090.00 1,993.00 170.00¢ 44.3 n/a -60% 280.00¢ 3.7%
31-Dec-19 24,384.00 1,548.00 103.00¢ 94.7 n/a -39% 280.00¢ 2.9%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

AstraZeneca Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 20,652.68 5,167.14 320.34p 21.2 0.1 +303% 216.27p 2.8%
31-Dec-21 22,936.13 6,427.25 402.78p 16.9 0.7 +26% 220.72p 2.9%

Copyright © 2020 FactSet Research Systems Inc. All rights reserved.

AstraZeneca Company Announcements

Director/PDMR Shareholding 27-Feb-2020 07:00 RNS
AstraZeneca divests global rights to Movantik 25-Feb-2020 07:00 RNS
Director/PDMR Shareholding 19-Feb-2020 07:00 RNS

Latest AstraZeneca Director Deals

Traded Action Notifier PriceAmountValue
26-Feb-20 Buy Tony Mok 7,441.98p 500 37,209.88
17-Feb-20 Buy Michel Demare 7,313.00p 700 51,191.00

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 6,794.00p
Change Today -348.00p
% Change -4.87 %
52 Week High 7,878.00p
52 Week Low 5,644.00p
Volume 4,469,668
Shares Issued 1,312.19m
Market Cap 89,150m
RiskGrade 142

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
36.35% below the market average36.35% below the market average36.35% below the market average36.35% below the market average36.35% below the market average
82.14% above the sector average82.14% above the sector average82.14% above the sector average82.14% above the sector average82.14% above the sector average
Price Trend
53.51% above the market average53.51% above the market average53.51% above the market average53.51% above the market average53.51% above the market average
52.73% above the sector average52.73% above the sector average52.73% above the sector average52.73% above the sector average52.73% above the sector average
Income
66.84% below the market average66.84% below the market average66.84% below the market average66.84% below the market average66.84% below the market average
63.64% above the sector average63.64% above the sector average63.64% above the sector average63.64% above the sector average63.64% above the sector average
Growth
91% below the market average91% below the market average91% below the market average91% below the market average91% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

What The Brokers Say

Strong Buy 21
Buy 1
Neutral 3
Sell 0
Strong Sell 3
Total 28
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  2nd Interim 1st Interim
Ex-Div 27-Feb-20 08-Aug-19
Paid 30-Mar-20 09-Sep-19
Amount 190.00¢ 90.00¢

Trades for 28-Feb-2020

Time Volume / Share Price
16:50 166 @ 6,729.00p
16:50 28 @ 6,786.50p
16:50 362 @ 6,807.15p
16:38 2,605 @ 6,794.00p
16:36 235 @ 6,794.00p

Top of Page